3.06
4.67%
-0.15
시간 외 거래:
3.00
-0.06
-1.96%
전일 마감가:
$3.21
열려 있는:
$3.23
하루 거래량:
190.79K
Relative Volume:
0.12
시가총액:
$40.71M
수익:
$128.60K
순이익/손실:
$-4.60M
주가수익비율:
-4.8571
EPS:
-0.63
순현금흐름:
$-3.74M
1주 성능:
+3.73%
1개월 성능:
-29.00%
6개월 성능:
+118.57%
1년 성능:
+684.41%
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
NXL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
3.06 | 40.71M | 128.60K | -4.60M | -3.74M | -0.63 |
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Certain Options of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World
How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register
Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire
Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com
Nexalin Launches AI-Powered Virtual Clinic Platform for Remote Mental Health Treatment Trials - StockTitan
Target Corp (TGT-N) QuotePress Release - The Globe and Mail
Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail
Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN
Nexalin Technology downgraded to Hold from Buy at Maxim - MSN
Maxim Group Downgrades Nexalin Technology (NXL) - MSN
Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com
Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq
New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire
Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan
Alibaba Group Holding ADR (BABA-N) QuotePress Release - The Globe and Mail
Nexalin Technology stock soars to all-time high of $4.07 - Investing.com
Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK
Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire
Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance
Nexalin Technology Inc (NXL) Quarterly 10-Q Report - Quartzy
Nexalin regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia
Nexalin regains Nasdaq compliance with bid price rule - Investing.com India
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th - The Manila Times
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewswire
Nexalin Technology : Regains Compliance with Nasdaq Continued Listing Requirements Form 8 K - Marketscreener.com
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - The Manila Times
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Nexalin technology's chief medical officer buys $1,095 in stock By Investing.com - Investing.com Canada
Nexalin technology's chief medical officer buys $1,095 in stock - Investing.com India
Significant Stock Increase For Nexalin (NXL) After Alzheimer’s Study Announcement - Stocks Telegraph
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients - AOL
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease - The Manila Times
Nexalin Technology Announces Landmark Study on Alzheimer's - GlobeNewswire
EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED) - Benzinga
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nexalin Technology Inc 주식 (NXL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Owens David | Chief Medical Officer |
Aug 13 '24 |
Buy |
0.95 |
1,000 |
950 |
147,793 |
Owens David | Chief Medical Officer |
Jun 28 '24 |
Buy |
1.75 |
1,000 |
1,750 |
146,793 |
Owens David | Chief Medical Officer |
Jun 18 '24 |
Buy |
0.71 |
1,619 |
1,149 |
145,793 |
Owens David | Chief Medical Officer |
Jun 10 '24 |
Buy |
0.64 |
3,000 |
1,920 |
144,174 |
자본화:
|
볼륨(24시간):